Journal: Oncology Letters

Article Title: METTL5-mediated m6A modification of 18S rRNA drives oral squamous cell carcinoma progression by enhancing CCND3 translation

doi: 10.3892/ol.2026.15490

Figure Lengend Snippet: METTL5 is elevated in HNSCC and is associated with poor prognosis of HNSCC. (A) Comparison of mRNA levels of METTL5 in HNSCC with normal tissues in TCGA-HNSCC dataset. (B) Overall survival of patients between METTL5-high (n=259) and METTL5-low (n=259) groups. (C) METTL5 expression level in normal and HNSCC tissues with different stages of lymph node metastasis. (D) METTL5 expression level in normal tissues and different stages of HNSCC tissues. (E) METTL5 expression level in normal HNSCC tissues and different grades of HNSCC tissues. (F) METTL5 protein level in OSCC(HSC3, SCC15) and HOK cell lines. (G) Representative bands of METTL5 protein expression levels in human OSCC and paired normal tissues measured by western blotting. (H) Semi-quantification of METTL5 protein expression levels in human OSCC and paired normal tissues. *P<0.05, **P<0.01; ***P<0.001. METTL5, methyltransferase 5, N6-adenosine; HNSCC, head and neck squamous cell carcinoma; TCGA, The Cancer Genome Atlas; OSCC, oral squamous cell carcinoma; HOK, human normal oral epithelial keratinocyte; HR, hazard ratio; TPM, transcripts per million; N, normal; T, tumor.

Article Snippet: SCC15 cells were purchased from the American Type Culture Collection (cat. no. CRL-1623).

Techniques: Comparison, Expressing, Western Blot

Journal: Oncology Letters

Article Title: METTL5-mediated m6A modification of 18S rRNA drives oral squamous cell carcinoma progression by enhancing CCND3 translation

doi: 10.3892/ol.2026.15490

Figure Lengend Snippet: Knockout of METTL5 inhibits the progression of OSCC in vitro . (A) Validation of METTL5 stable knockout in SCC15 cells by western blotting. Results of (B) Cell Counting Kit-8 assay, (C) colony formation assay, (D) Transwell assay and (E) wound healing assay after knockout of METTL5 in SCC15 cells. *P<0.05, **P<0.01; ***P<0.001; ****P<0.0001. METTL5, methyltransferase 5, N6-adenosine; NC, negative control; OSCC, oral squamous cell carcinoma; sg, small guide RNA; NC, negative control; OD, optical density.

Article Snippet: SCC15 cells were purchased from the American Type Culture Collection (cat. no. CRL-1623).

Techniques: Knock-Out, In Vitro, Biomarker Discovery, Western Blot, Cell Counting, Colony Assay, Transwell Assay, Wound Healing Assay, Negative Control

Journal: Oncology Letters

Article Title: METTL5-mediated m6A modification of 18S rRNA drives oral squamous cell carcinoma progression by enhancing CCND3 translation

doi: 10.3892/ol.2026.15490

Figure Lengend Snippet: Overexpression of METTL5 promotes the progression of OSCC. (A) Validation of METTL5 overexpression in SCC15 cells by western blotting. (B) Results of the Cell Counting Kit-8 assay after METTL5 overexpression in SCC15 cells. (C) Statistical results of the Transwell assay after METTL5 overexpression in SCC15 cells. (D) Results of the colony formation assay after knockout of METTL5 in SCC15 cells. **P<0.01. METTL5, methyltransferase 5, N6-adenosine; OSCC, oral squamous cell carcinoma; oe, overexpression; NC, negative control; OD, optical density.

Article Snippet: SCC15 cells were purchased from the American Type Culture Collection (cat. no. CRL-1623).

Techniques: Over Expression, Biomarker Discovery, Western Blot, Cell Counting, Transwell Assay, Colony Assay, Knock-Out, Negative Control

Journal: Oncology Letters

Article Title: METTL5-mediated m6A modification of 18S rRNA drives oral squamous cell carcinoma progression by enhancing CCND3 translation

doi: 10.3892/ol.2026.15490

Figure Lengend Snippet: Inhibition of METTL5 suppresses tumor growth in vivo . (A) Representative images of subcutaneous tumors from the SCC15 cell mouse model. (B) Quantification of tumor weight and tumor volume. (C) Tumor volume changes during treatment. (D) Quantitative analysis of IHC scores for METTL5 and Ki-67 expression. (E) Representative images of METTL5 and Ki-67 staining. **P<0.01; ***P<0.001. METTL5, methyltransferase 5, N6-adenosine; sg, small guide RNA; NC, negative control; IHC, immunohistochemistry.

Article Snippet: SCC15 cells were purchased from the American Type Culture Collection (cat. no. CRL-1623).

Techniques: Inhibition, In Vivo, Expressing, Staining, Negative Control, Immunohistochemistry

Journal: Oncology Letters

Article Title: METTL5-mediated m6A modification of 18S rRNA drives oral squamous cell carcinoma progression by enhancing CCND3 translation

doi: 10.3892/ol.2026.15490

Figure Lengend Snippet: Knockout of METTL5 selectively inhibits the translation of oncogenic mRNAs. (A) TE scatter plot of METTL5 knockout and control SCC15 cells. (B) Pathway enrichment of TE-downregulated genes. (C) Western blotting confirmed the decreased protein levels of CCND3 in METTL5 knockout SCC15 cells. METTL5, methyltransferase 5, N6-adenosine; TE, translation efficiency; CCND3, cyclin D3; sg, small guide RNA; NC, negative control.

Article Snippet: SCC15 cells were purchased from the American Type Culture Collection (cat. no. CRL-1623).

Techniques: Knock-Out, Control, Western Blot, Negative Control

Journal: Journal of Oral Biology and Craniofacial Research

Article Title: High expression of TRMT112 is associated with the development of oral squamous cell carcinoma

doi: 10.1016/j.jobcr.2025.12.014

Figure Lengend Snippet: TRMT112 was highly expressed in OSCC and associated with poor prognosis. (A) qPCR analysis showed that TRMT1 12 mRNA was significantly increased in OSCC tissues compared to matched adjacent non-tumor tissues. (B) qPCR analysis revealed that TRMT1 12 mRNA was highly expressed in OSCC cell lines when compared to normal oral keratinocyte cell line. (C) TRMT1 12 mRNA was significantly overexpressed in the OSCC-TCGA dataset. (D) TRMT1 12 mRNA was significantly overexpressed in the HNSCC-TCGA dataset. (E, F) Kaplan-Meier and log-rank testing showed the prognosis of the patient cohort (overall and disease-free survival).

Article Snippet: CAL27, SCC25, and SCC15 OSCC cell lines were obtained from the American Type Culture Collection (ATCC, USA) and confirmed to be negative for mycoplasma.

Techniques:

Journal: Journal of Oral Biology and Craniofacial Research

Article Title: High expression of TRMT112 is associated with the development of oral squamous cell carcinoma

doi: 10.1016/j.jobcr.2025.12.014

Figure Lengend Snippet: Protein expression of TRMT112 in OSCC tissues. (A) Western blot analysis showed that TRMT112 protein expression significantly increased in OSCC compared with adjacent non-tumor tissues. (B) HNSCC-TCGA dataset revealed that the expression of TRMT112 was up-regulated in HNSCC tissues compared to normal tissues. (C) Immunohistochemistry analysis also indicated that TRMT112 was highly expressed in tumor tissues when compared to normal tissues.

Article Snippet: CAL27, SCC25, and SCC15 OSCC cell lines were obtained from the American Type Culture Collection (ATCC, USA) and confirmed to be negative for mycoplasma.

Techniques: Expressing, Western Blot, Immunohistochemistry

Journal: Journal of Oral Biology and Craniofacial Research

Article Title: High expression of TRMT112 is associated with the development of oral squamous cell carcinoma

doi: 10.1016/j.jobcr.2025.12.014

Figure Lengend Snippet: Networks, pathways, and diseases associated with TRMT112. (A, B) TRMT112 protein network. (C) Functional enrichment analysis of the TRMT112 protein interactions associated with cancer-linked pathways. (D) TRMT112 expression positively correlated with METTL5 expression. (E) High expression of METTL5 in OSCC patients (TCGA-OSCC dataset).

Article Snippet: CAL27, SCC25, and SCC15 OSCC cell lines were obtained from the American Type Culture Collection (ATCC, USA) and confirmed to be negative for mycoplasma.

Techniques: Functional Assay, Expressing